GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi Consumer Healthcare India Ltd (BOM:544250) » Definitions » Change In Receivables

Sanofi Consumer Healthcare India (BOM:544250) Change In Receivables : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Sanofi Consumer Healthcare India Change In Receivables?

Sanofi Consumer Healthcare India's change in receivables for the quarter that ended in Dec. 2024 was ₹0 Mil. It means Sanofi Consumer Healthcare India's Accounts Receivable stayed the same from Sep. 2024 to Dec. 2024 .

Sanofi Consumer Healthcare India's change in receivables for the fiscal year that ended in Dec. 2024 was ₹178 Mil. It means Sanofi Consumer Healthcare India's Accounts Receivable declined by ₹178 Mil from Dec. 2023 to Dec. 2024 .

Sanofi Consumer Healthcare India's Accounts Receivable for the quarter that ended in Dec. 2024 was ₹137 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sanofi Consumer Healthcare India's Days Sales Outstanding for the three months ended in Dec. 2024 was 6.92.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sanofi Consumer Healthcare India's liquidation value for the three months ended in Dec. 2024 was ₹1,993 Mil.

Sanofi Consumer Healthcare India Change In Receivables Historical Data

The historical data trend for Sanofi Consumer Healthcare India's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Consumer Healthcare India Change In Receivables Chart

Sanofi Consumer Healthcare India Annual Data
Trend Dec23 Dec24
Change In Receivables
-3.00 178.00

Sanofi Consumer Healthcare India Quarterly Data
Sep23 Dec23 Sep24 Dec24
Change In Receivables - - - -

Sanofi Consumer Healthcare India Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Consumer Healthcare India  (BOM:544250) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sanofi Consumer Healthcare India's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=137/1807*91
=6.92

2. In Ben Graham's calculation of liquidation value, Sanofi Consumer Healthcare India's accounts receivable are only considered to be worth 75% of book value:

Sanofi Consumer Healthcare India's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=3269-1583+0.75 * 137+0.5 * 409
=1,993

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Consumer Healthcare India Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sanofi Consumer Healthcare India's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi Consumer Healthcare India Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi Consumer Healthcare India Ltd (BOM:544250) » Definitions » Change In Receivables
Comparable Companies
NSE:MARKSANS BOM:500674 NSE:PFIZER NSE:SENORES BOM:532815 BOM:507747 BOM:524280 BOM:524774 BOM:500660 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN PFE GILD
Traded in Other Exchanges
SANOFICONR:India
Address
Saki Vihar Road, L&T business park, 3rd Floor, Sanofi House, CTS No. 117-B, Powai, Mumbai, MH, IND, 400072
Website
https://www.sanofiindialtd.com
Sanofi Consumer Healthcare India Ltd is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all varieties of pharmaceuticals especially consumer healthcare products.

Sanofi Consumer Healthcare India Headlines

No Headlines